MDM2 anticorps (pSer166)
Aperçu rapide pour MDM2 anticorps (pSer166) (ABIN362482)
Antigène
Voir toutes MDM2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer166
-
Specificité
- The antibody detects endogenous level of MDM2 only when phosphorylated at serine 166.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
Immunogène
- Peptide sequence around phosphorylation site of pSer166 (A-I-S (p) -E-T) derived from Human MDM2. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western blotting: 1:500-1:1000
Immunohistochemistry: 1:50-1:100
Immunofluorescence: 1:100-1:200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
-
: "Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53." dans: Molecular and cellular biology, Vol. 31, Issue 9, pp. 1788-99, (2011) (PubMed).
: "N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy." dans: The American journal of pathology, Vol. 177, Issue 1, pp. 132-40, (2010) (PubMed).
-
-
- MDM2 (Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2))
-
Autre désignation
- MDM2
-
Sujet
- This gene is a target gene of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of this gene can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle, apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5. More than 40 different alternatively spliced transcript variants have been isolated from both tumor and normal tissues
-
Poids moléculaire
- 90 kDa
-
NCBI Accession
- NP_002383
-
UniProt
- Q00987
-
Pathways
- Signalisation p53, Signalisation PI3K-Akt, Cycle Cellulaire, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Autophagy, Ubiquitin Proteasome Pathway
Antigène
-